Piroxicam was excluded from the list among drugs that should not be taken with Paxlovid, an oral COVID-19 treatment. As a result, the number of combination contraindications has decreased to 16, but there are many contraindications, making it difficult for patients with chronic diseases who take drugs every day to take Piroxicam.

The HIRA announced on the 5th that it will delete the Piroxicam-containing drug among the concomitant of the drug Paxlovid (Nirmatrelvir+Ritonavi) and Pfizer Pharmaceutical, which were approved for emergency use in COVID-19.

Piroxicam is a nonsteroidal anti-inflammatory drug and] is used to relieve inflammation such as arthritis. Until now, Piroxicam has been one